Age of Diagnosis for Children with Chromosome 15q Syndromes

Abstract Objective: The objective of this study was to identify the age of diagnosis for children with one of three neurogenetic conditions resulting from changes on chromosome 15 (Angelman syndrome [AS], Prader-Willi syndrome [PWS], and Duplication 15q syndrome [Dup15q]). Methods: Data about diagnostic process for each condition were contributed by the advocacy organizations. Median and interquartile ranges were calculated for each condition by molecular subtype and year. Comparison tests were run to explore group differences. Results. The median age of diagnosis was 1.8 years for both AS and Dup15q. PWS was diagnosed significantly younger at a median age of 1 month. Deletion subtypes for both PWS and AS were diagnosed earlier than nondeletion subtypes, and children with isodicentric duplications in Dup15q were diagnosed earlier than those with interstitial duplications. Conclusion. Understanding variability in age of diagnosis for chromosome 15 disorders is an important step in reducing the diagnostic odyssey and improving access to interventions for these populations. Results from this study provide a baseline by which to evaluate efforts to reduce the age of diagnosis for individuals with these conditions.